Advertisement Misonix signs new distribution agreement with Eclipse Medical - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Misonix signs new distribution agreement with Eclipse Medical

Misonix, a developer of minimally invasive ultrasonic medical device technology, has entered into a new, three year, exclusive distribution agreement with Eclipse Medical, based in Rotterdam, the Netherlands, for the distribution of the SonaStar ultrasonic surgical aspirator, the BoneScalpel ultrasonic bone cutter, and the SonicOne ultrasonic wound debrider.

The agreement provides Eclipse Medical with the rights to sell in the Netherlands, and includes minimum purchase requirements.

The SonaStar is used by neuro and general surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.

The SonicOne is an ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable cellular structures, the company said.

Michael McManus, Jr, president and CEO of Misonix, said: “Eclipse Medical’s commitments to quality and service to its clinical customers, as well as their track record of successfully introducing high tech medical devices to their market, was quite appealing to Misonix. We are excited about partnering with them and we are particularly pleased that they will be distributing three of our products through their well established distribution network.”